Trial intelligence / Profile preview

Topical Pentoxifylline for Behcet's Disease Oral Ulcers

NCT03888846Phase 2Completed

Sponsor
Ipekyolu Ilac Ltd. Sti
Start
Mar 2019
Primary completion
Aug 2019
Modality
Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pentoxifylline PKB171 gel in Behcet's disease (BD), sponsored by Ipekyolu Ilac Ltd. Sti. Started Mar 2019; status: completed.

02

Drugs

pentoxifylline PKB171 gel
03

Conditions

Behcet's disease (BD)

Beyond the preview

Go deeper on NCT03888846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03888846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call